BIT Capital GmbH Sells 153 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

BIT Capital GmbH lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 53.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 134 shares of the medical equipment provider’s stock after selling 153 shares during the quarter. BIT Capital GmbH’s holdings in Intuitive Surgical were worth $70,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in ISRG. Howard Capital Management Group LLC grew its stake in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after acquiring an additional 9,194 shares during the period. Quest Partners LLC bought a new position in Intuitive Surgical in the 3rd quarter valued at $173,000. Algert Global LLC purchased a new stake in Intuitive Surgical in the third quarter worth $1,988,000. Finally, Larson Financial Group LLC lifted its position in shares of Intuitive Surgical by 79.4% during the third quarter. Larson Financial Group LLC now owns 854 shares of the medical equipment provider’s stock worth $420,000 after purchasing an additional 378 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $509.03 on Thursday. The business’s 50-day moving average is $559.82 and its 200 day moving average is $532.42. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market capitalization of $181.31 billion, a P/E ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.43.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Robert W. Baird lowered their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Piper Sandler reissued an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.